JP2005501534A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005501534A5 JP2005501534A5 JP2003510808A JP2003510808A JP2005501534A5 JP 2005501534 A5 JP2005501534 A5 JP 2005501534A5 JP 2003510808 A JP2003510808 A JP 2003510808A JP 2003510808 A JP2003510808 A JP 2003510808A JP 2005501534 A5 JP2005501534 A5 JP 2005501534A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- polynucleotide
- infection
- seq
- host
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229920001184 polypeptide Polymers 0.000 claims 67
- 102000004196 processed proteins & peptides Human genes 0.000 claims 67
- 108090000765 processed proteins & peptides Proteins 0.000 claims 67
- 108091033319 polynucleotide Proteins 0.000 claims 20
- 239000002157 polynucleotide Substances 0.000 claims 20
- 102000040430 polynucleotide Human genes 0.000 claims 20
- 208000015181 infectious disease Diseases 0.000 claims 10
- 241000193990 Streptococcus sp. 'group B' Species 0.000 claims 7
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 6
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 6
- 230000000890 antigenic effect Effects 0.000 claims 6
- 230000002163 immunogen Effects 0.000 claims 6
- 239000000203 mixture Substances 0.000 claims 6
- 230000000295 complement effect Effects 0.000 claims 5
- 239000012634 fragment Substances 0.000 claims 5
- 125000000539 amino acid group Chemical group 0.000 claims 4
- 239000012472 biological sample Substances 0.000 claims 4
- 230000001225 therapeutic effect Effects 0.000 claims 4
- 201000009906 Meningitis Diseases 0.000 claims 3
- 206010040047 Sepsis Diseases 0.000 claims 3
- 206010061372 Streptococcal infection Diseases 0.000 claims 3
- 238000003745 diagnosis Methods 0.000 claims 3
- 206010014665 endocarditis Diseases 0.000 claims 3
- 206010007882 Cellulitis Diseases 0.000 claims 2
- 206010031252 Osteomyelitis Diseases 0.000 claims 2
- 206010035664 Pneumonia Diseases 0.000 claims 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 claims 2
- 230000003449 preventive effect Effects 0.000 claims 2
- 230000000069 prophylactic effect Effects 0.000 claims 2
- 230000003248 secreting effect Effects 0.000 claims 2
- 206010053555 Arthritis bacterial Diseases 0.000 claims 1
- 208000031729 Bacteremia Diseases 0.000 claims 1
- 108020004414 DNA Proteins 0.000 claims 1
- 201000009273 Endometriosis Diseases 0.000 claims 1
- 206010016228 Fasciitis Diseases 0.000 claims 1
- 208000004575 Infectious Arthritis Diseases 0.000 claims 1
- 206010062255 Soft tissue infection Diseases 0.000 claims 1
- 206010048038 Wound infection Diseases 0.000 claims 1
- 206010000269 abscess Diseases 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- 238000012258 culturing Methods 0.000 claims 1
- 235000013365 dairy product Nutrition 0.000 claims 1
- 238000001514 detection method Methods 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 210000002409 epiglottis Anatomy 0.000 claims 1
- 244000144980 herd Species 0.000 claims 1
- 244000144972 livestock Species 0.000 claims 1
- 208000004396 mastitis Diseases 0.000 claims 1
- 239000002773 nucleotide Substances 0.000 claims 1
- 125000003729 nucleotide group Chemical group 0.000 claims 1
- 206010034674 peritonitis Diseases 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 201000001223 septic arthritis Diseases 0.000 claims 1
- 206010040872 skin infection Diseases 0.000 claims 1
- 230000002485 urinary effect Effects 0.000 claims 1
- 208000019206 urinary tract infection Diseases 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30310101P | 2001-07-06 | 2001-07-06 | |
| PCT/CA2002/001019 WO2003004650A2 (en) | 2001-07-06 | 2002-07-05 | Group b streptococcus antigens and corresponding dna fragments |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009139587A Division JP5194199B2 (ja) | 2001-07-06 | 2009-06-10 | グループｂ連鎖球菌の抗原及び対応するｄｎａ断片 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2005501534A JP2005501534A (ja) | 2005-01-20 |
| JP2005501534A5 true JP2005501534A5 (https=) | 2006-01-12 |
| JP4374245B2 JP4374245B2 (ja) | 2009-12-02 |
Family
ID=23170538
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003510808A Expired - Fee Related JP4374245B2 (ja) | 2001-07-06 | 2002-07-05 | グループｂ連鎖球菌の抗原及び対応するｄｎａ断片 |
| JP2009139587A Expired - Fee Related JP5194199B2 (ja) | 2001-07-06 | 2009-06-10 | グループｂ連鎖球菌の抗原及び対応するｄｎａ断片 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009139587A Expired - Fee Related JP5194199B2 (ja) | 2001-07-06 | 2009-06-10 | グループｂ連鎖球菌の抗原及び対応するｄｎａ断片 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US7393536B2 (https=) |
| EP (1) | EP1407023B1 (https=) |
| JP (2) | JP4374245B2 (https=) |
| AT (1) | ATE452191T1 (https=) |
| AU (1) | AU2002317107B2 (https=) |
| BR (1) | BR0210875A (https=) |
| CA (1) | CA2453062C (https=) |
| DE (1) | DE60234772D1 (https=) |
| ES (1) | ES2337773T3 (https=) |
| WO (1) | WO2003004650A2 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2881568C (en) * | 2000-10-27 | 2019-09-24 | Novartis Vaccines And Diagnostics, Inc. | Nucleic acids and proteins from streptococcus groups a & b |
| AU2002216863B8 (en) * | 2000-12-21 | 2008-03-20 | Id Biomedical Corporation | Streptococcus pyogenes antigens and corresponding DNA fragments |
| AU2002360628A1 (en) * | 2001-12-21 | 2003-07-30 | Children's Hospital & Regional Medical Center | Use of a novel cell surface protease from Group B Streptococcus |
| US8877909B2 (en) | 2011-04-04 | 2014-11-04 | Intelligent Medical Devices, Inc. | Optimized oligonucleotides and methods of using same for the detection, isolation, amplification, quantitation, monitoring, screening, and sequencing of group B Streptococcus |
| KR101675382B1 (ko) | 2015-04-07 | 2016-11-14 | (주) 씨에스코리아 | 황토보드 제조방법 및 그에 의해 제조되는 황토보드 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL107026A0 (en) | 1992-09-16 | 1993-12-28 | Univ Tennessee Res Corp | Antigen of hybrid m protein and carrier for group a streptococcal vaccine |
| ATE349527T1 (de) | 1997-09-12 | 2007-01-15 | Univ Tennessee Res Foundation | Gruppe a streptokokken-impfstoff |
| KR100802198B1 (ko) * | 1998-12-23 | 2008-02-11 | 샤이어 바이오켐 인코포레이티드 | 신규한 스트렙토코커스 항원 |
| GB9921125D0 (en) | 1999-09-07 | 1999-11-10 | Microbial Technics Limited | Proteins |
| CA2881568C (en) * | 2000-10-27 | 2019-09-24 | Novartis Vaccines And Diagnostics, Inc. | Nucleic acids and proteins from streptococcus groups a & b |
| FR2824074A1 (fr) | 2001-04-26 | 2002-10-31 | Pasteur Institut | Sequence du genome streptococcus agalactiae, application au developpement de vaccins, d'outils de diagnostic, et a l'identification de cibles therapeutiques |
| EP1456231A2 (en) | 2001-12-20 | 2004-09-15 | Shire Biochem Inc. | Streptococcus antigens |
-
2002
- 2002-07-05 BR BR0210875-5A patent/BR0210875A/pt active Search and Examination
- 2002-07-05 EP EP02745009A patent/EP1407023B1/en not_active Expired - Lifetime
- 2002-07-05 WO PCT/CA2002/001019 patent/WO2003004650A2/en not_active Ceased
- 2002-07-05 DE DE60234772T patent/DE60234772D1/de not_active Expired - Lifetime
- 2002-07-05 JP JP2003510808A patent/JP4374245B2/ja not_active Expired - Fee Related
- 2002-07-05 ES ES02745009T patent/ES2337773T3/es not_active Expired - Lifetime
- 2002-07-05 US US10/482,929 patent/US7393536B2/en not_active Expired - Lifetime
- 2002-07-05 CA CA2453062A patent/CA2453062C/en not_active Expired - Fee Related
- 2002-07-05 AU AU2002317107A patent/AU2002317107B2/en not_active Ceased
- 2002-07-05 AT AT02745009T patent/ATE452191T1/de not_active IP Right Cessation
-
2008
- 2008-06-09 US US12/135,911 patent/US7740870B2/en not_active Expired - Lifetime
-
2009
- 2009-06-10 JP JP2009139587A patent/JP5194199B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Hayman et al. | Mapping the minimal murine T cell and B cell epitopes within a peptide vaccine candidate from the conserved region of the M protein of group A streptococcus. | |
| US7160990B2 (en) | Antibodies to a fibrinogen binding protein of staphylococcus epidermidis | |
| CA2356836A1 (en) | Novel streptococcus antigens | |
| EP2292647A2 (en) | Small Streptococcus pyogenes antigens and their use | |
| US5610011A (en) | Virulence-encoding DNA sequences of Strepococcus suis and related products and methods | |
| AU2008204471B2 (en) | Protective proteins of S. agalactiae, combinations thereof and methods of using the same | |
| CA2535799A1 (en) | Identification of porphyromonas gingivalis virulence polynucleotides for diagnosis, treatment, and monitoring of periodontal diseases | |
| WO1992017588A2 (en) | METHOD FOR PRODUCTION OF AN IgA BINDING PROTEIN DERIVED FROM GROUP B STREPTOCOCCI | |
| CA2475821A1 (en) | Group b streptococcus antigens | |
| JP2005535287A5 (https=) | ||
| Kling et al. | Characterization of two distinct opsonic and protective epitopes within the alpha C protein of the group B Streptococcus | |
| JP2005501534A5 (https=) | ||
| JP5194199B2 (ja) | グループｂ連鎖球菌の抗原及び対応するｄｎａ断片 | |
| JP2004531235A5 (https=) | ||
| CA2438921A1 (en) | Streptococcus pyogenes polypeptides and corresponding dna fragments | |
| JP2006502696A (ja) | 病原菌株に特異的な新規生成物およびそのワクチンとしての使用および免疫療法における使用 | |
| CA2466474A1 (en) | Compositions comprising spa-1, spa-2 and spa-3, polypeptides and related uses | |
| EP0726314A1 (en) | FIMBRILLIN PROTEIN OF $i(PORPHYROMONAS GINGIVALIS) | |
| JP2005524387A5 (https=) | ||
| CA2432525A1 (en) | Streptococcus pyogenes antigens and corresponding dna fragments | |
| CA2411927A1 (en) | Immunization of dairy cattle with gapc protein against streptococcus infection | |
| RU2387715C2 (ru) | РЕКОМБИНАНТНЫЕ ДНК, ОБЕСПЕЧИВАЮЩИЕ ПОЛУЧЕНИЕ ПОЛИПЕПТИДОВ Р6, Р7, Р8, ОБЛАДАЮЩИХ ПРОТЕКТИВНЫМИ СВОЙСТВАМИ В ОТНОШЕНИИ STREPTOCOCCUS AGALACTIAE И СЕЛЕКТИВНО-СВЯЗЫВАЮЩИХ IgA | |
| WO2001025440A1 (en) | C3 binding polypeptide of streptococcus agalactiae, group b streptococcus | |
| WO1997003359A1 (en) | Helicobacter clpb | |
| JP2001504335A (ja) | ストレプトコッカス・ユベリスのラクトフェリン結合タンパク質 |